Analyst stock forecast
Biogen Forecast: $266.39 Analyst Target
Direct answer
Biogen's average price target is $266.39.
The target implies +7.3% from the recorded current price, and the consensus rating is Buy.
The low target implies -29.5%, the high target implies +40.9%, and the range spans 70.5% of the current price.
Forecast evidence checked November 8, 2026.
Get free Biogen email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $248.35
- Average price target
- $266.39
- High price target
- $350.00
- Low price target
- $175.00
- Low target gap
- -29.5%
- Target upside
- +7.3%
- High target gap
- +40.9%
- Target range width
- 70.5%
- Consensus rating
- Buy
- Analysts
- 32
- Evidence date
- November 8, 2026
- Valid through
- November 15, 2026
Explore related company data
Read the frequently asked questions.
What is Biogen's average price target?
Biogen's verified average price target is $266.39. The target range is $175.00 to $350.00.
How far are Biogen's low and high targets from the recorded price?
The low target implies -29.5%, while the high target implies +40.9%.
How many analysts are included in Biogen's consensus?
The verified consensus includes 32 analysts.
How is Biogen's target upside or downside calculated?
The average target of $266.39 is divided by the recorded price of $248.35, then one is subtracted to produce +7.3%. This does not guarantee a future return.
When was Biogen's analyst forecast verified?
The data was verified on 2026-11-08. The dataset is valid through 2026-11-15.